期刊文献+

老年系统炎症反应综合征患者炎症因子水平改变及其临床意义的研究 被引量:5

原文传递
导出
摘要 目的 研究系统炎症反应综合征(SIRS)患者内毒素(ET)及炎症因子水平的改变及其临床意义.方法 选择2012年6月至2014年6月住院的45例老年发热患者,分别于入住病房当天记录患者体温、呼吸次数、心率,并采集外周血,检测血常规,评定SIRS评分.依据SIRS评分标准将45例老年SIRS患者分成3组:2分组(15例)、3分组(15例)、4分组(15例).同时设立门诊“老年健康体检者”对照组(15例).采用化学发光法测定血IL-1β、IL-6、TNF-α水平,采用光度法检测ET水平.结果 SIRS 2分组、3分组、4分组患者的IL-1β、IL-6、TNF-α、ET水平均明显高于健康对照组(P<0.05),差异均有统计学意义.SIRS 2分组、3分组IL-1β、IL-6、TNF-α、ET水平组间比较,差异无统计学意义(P>0.05).SIRS 2分组与4分组患者、SIRS 3分组与4分组患者的IL-1β、IL-6、TNF-α、ET水平组间比较,差异均有统计学意义(P<0.05).结论 检测老年SIRS患者的IL-1β、IL-6、TNF-α、ET水平可预测SIRS严重程度。
出处 《中国医师杂志》 CAS 2015年第6期907-908,共2页 Journal of Chinese Physician
基金 上海中医药大学附属普陀医院(上海市普陀区中心医院)院级课题资助项目(2013PT056)
  • 相关文献

参考文献8

  • 1盛志勇 胡森.多器官功能障碍综合症[M].北京:科学出版社,2000.44.
  • 2Keh D.Immunocompetence in the critically ill:understanding the problem[J].Minerva Anestesiol,2000,66(5):358-361.
  • 3Bone RC.Immunologic dissonance:a continuing evolution in our understanding of the systemic inflammatory response syndrome(SIRS)and the multiple organ dysfunction syndrome(MODS)[J].Ann Intern Med,1996,125(8):680-687.
  • 4Jacobi J.Pathophysiology of sepsis[J].Am J Health Syst Pharm,2002,59 Suppl 1:S3-S8.
  • 5Morris PE,Hite RD,Ohl C.Relationship between the inflammation and coagulation pathways in patients with severe sepsis:implications for therapy with activated protein C[J].Bio Drugs,2002,16(6):403-417.
  • 6Chadzinska M,Starowicz K,Scislowska-Czamecka A,et al.Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice[J].Immunol Lett,2005,101(2):185-192.
  • 7张予阳,刘岩,付守廷.脑缺血与炎症反应[J].中国药理学通报,2006,22(1):5-9. 被引量:52
  • 8Papathanassoglou ED,Movnihan JA,Dafni 0,et al.Association of proinflammatory molecules with apoptotic markers and survival in critically ill multiple organ dysfunction patients[J].Biol Res Nurs,2003.5?2):129-141.

二级参考文献24

  • 1徐秋琴,魏尔清,俞月萍,张琦,张世红,朱朝阳.半胱氨酰白三烯受体拮抗剂pranlukast对小鼠局灶性脑缺血的治疗作用[J].中国药理学通报,2004,20(7):758-761. 被引量:6
  • 2张剑辉,宋慧君,李淑媛.雏菊叶龙胆酮对局灶性脑缺血损伤的保护作用及机制探讨[J].中国药理学通报,2005,21(2):220-224. 被引量:17
  • 3余涓,邱丽颖,周宇,陈柏龄,郑祥,陈崇宏.脑缺血再灌注损伤后神经细胞凋亡及Bcl-2、Bax蛋白表达与罗非昔布的影响[J].中国药理学通报,2005,21(5):572-575. 被引量:16
  • 4Ritter LS,Orozco JA,Coull BM et al.Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke[J].Stroke,2000,31(5):1153-61.
  • 5Steiner DR,Gonzalez NC,Wood JG.Mast cells mediate the microvascular inflammatory response to systemic hypoxia[J].J Appl Physiol,2003,94(1):325-34.
  • 6Michaloudi H,Grivas I,Batzios C et al.Parallel development of blood vessels and mast cells in the lateral geniculate nuclei[J].Dev Brain Res,2003,140 (2):269-76.
  • 7Schielke GP,Yang GY,Silverstein FS et al.Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage[J].J Cereb Blood Flow Meteb,1999,19(10):1099-108.
  • 8Savitz SI,Erhardt JA,Anthony JV et al.The novel beta-blocker,carvedilol,provides neuroprotection in transient focal stroke[J].J Cereb Blood Flow Metab,2000,20(8):1197-204.
  • 9Ma XC,Gottschall PE,Chen LT et al.Role and mechanisms of interleukin-1 in the modulation of neurotoxicity[J].Neuroimmunomodulation,2002~2003,10(4):199-207.
  • 10Gong C,Qin Z,Betz AL et al.Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice[J].Brain Res,1998,801(1~2):1-8.

共引文献52

同被引文献43

  • 1Hamacher L, Dorfelt R, Muller M, et al. Serum cardiac troponin Iconcentrations in dogs with systemic inflammatory response syn-drome[J].J Vet Intern Med, 2015,29(1):164-170.
  • 2Bemardi M, Moreau R, Angeli P, et al. Mechanisms of decompen-sation and organ failure in cirrhosis: From peripheral arterial va-sodilation to systemic inflammation hypothesis [J]. J Hepatol, 2015,63(5):1272-1284.
  • 3Lin S, Huang Z,Wang M, et al. Interleukin-6 as an early diagnosticmarker for bacterial sepsis in patients with liver cirrhosis [J]. J CritCare, 2015,30(4):732-738.
  • 4Reuken PA, Kussmann A, Kiehntopf M, et al. Imbalance of vonWillebrand factor and its cleaving protease ADAMTS13 during sys-temic inflammation superimposed on advanced cirrhosis [J]. LiverInt, 2015,35(1):37-45.
  • 5American College of Chest Physicians/Society of Critical CareMedicine Consensus Conference: definitions for sepsis and organfailure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992,20(6):864-874.
  • 6Arvaniti V,D'Amico G, Fede G, et al. Infections in patients withcirrhosis increase mortality four-fold and should be used in deter-mining prognosis [J]. Gastroenterology, 2010,139 (4):1246-1256,1251-1256.
  • 7Mehta G,Mookerjee R P, Sharma V,et al. Systemic inflammationis associated with increased intrahepatic resistance and mortality inalcohol-related acute-on-chronic liver failure [J]. Liver Int, 2015,35(3):724-734.
  • 8Thabut D, Massard J, Gangloff A, et al. Model for end-stage liverdisease score and systemic inflammatory response are major prog-nostic factors in patients with cirrhosis and acute functional renalfailure[J]. Hepatology,2007,46(6): 1872-1882.
  • 9Torrente C, Manzanilla E G, Bosch L, et al. Plasma iron, C-reactiveprotein, albumin, and plasma fibrinogen concentrations in dogswith systemic inflammatory response syndrome [J]. J Vet EmergCrit Care (San Antonio), 2015,25(5):611-619.
  • 10Ratzinger F, Haslacher H, Perkmann T, et al. Sepsis biomarkers inneutropaenic systemic inflammatory response syndrome patients onstandard care wards[J]. Eur J Clin Invest, 2015,45(8):815-823.

引证文献5

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部